Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine and PEG-asparaginase in Older Adults with ALL
NCT00973752Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 2009
- Primary completion
- Dec 2014
- Modality
- Therapeutic Enzymes, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine, pegaspargase in acute lymphoblastic leukemia (ALL), sponsored by Massachusetts General Hospital. Started Aug 2009; status: completed.
02
Drugs
clofarabinepegaspargase
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00973752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00973752.